Nurix Therapeutics, Inc.
Net SellingNRIX·US·🇺🇸 US
0%buys·100%sells
964 transactions$0Total buys·0 buys
$10.4MTotal sells·155 sells
3939 insiders
Last: Apr 2, 2026
van Houte Hans (CFO) recently executed a sell of $79K in Nurix Therapeutics, Inc. shares on November 3, 2025. Overall insider sentiment is bearish (100% sales).
Nurix Therapeutics, Inc. (NRIX) has recorded 964 insider operations, including 0 open-market purchases ($0), 155 sales ($10.4M) and 809 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is bearish (100% sales).
Among the most active insiders are SANDS ARTHUR T (CEO), van Houte Hans (CFO) & Ring Christine (C SUITE), with respectively 48, 124, 206 transactions.
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
Advanced analytics coming soon
Price impact analysis, win rates, and predictive signals are being developed.